SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Ron who wrote (1117)3/24/2000 11:12:00 AM
From: Cheryl Galt  Respond to of 1386
 
Might FDA allow ICP as an end point?
Last Jan 25th, Dr. Tracy (www.neuroinvestment.com) definitely thought not.

See the prior discussion of FDA's attitude, in posts near here:

Message 12670063



To: Ron who wrote (1117)3/24/2000 3:52:00 PM
From: arnie h  Read Replies (1) | Respond to of 1386
 
Ron: Certainly worth a try but problematic as you can see from Cheryl's post. Hopefully, our clinical investigators can work out something practical.
Arnie